Progress and prospects for blood-stage malaria vaccines
- PMID: 26760062
- PMCID: PMC4915341
- DOI: 10.1586/14760584.2016.1141680
Progress and prospects for blood-stage malaria vaccines
Abstract
There have been significant decreases in malaria mortality and morbidity in the last 10-15 years, and the most advanced pre-erythrocytic malaria vaccine, RTS,S, received a positive opinion from European regulators in July 2015. However, no blood-stage vaccine has reached a phase III trial. The first part of this review summarizes the pros and cons of various assays and models that have been and will be used to predict the efficacy of blood-stage vaccines. In the second part, blood-stage vaccine candidates that showed some efficacy in human clinical trials or controlled human malaria infection models are discussed. Then, candidates under clinical investigation are described in the third part, and other novel candidates and strategies are reviewed in the last part.
Keywords: Malaria; Plasmodium falciparum; blood-stage; challenge models; clinical trial; in vitro assays; vaccine.
References
-
- WHO [[cited Oct 23; 2015]];World Malaria Report 2014. http://www.who.int/malaria/publications/world_malaria_report_2014/en/ Available from:
-
- White NJ, Pukrittayakamee S, Hien TT. Malaria. Lancet. 2014;383:723–735. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous